Cargando…
Mid-term treatment-related cognitive sequelae in glioma patients
PURPOSE: Cognitive functioning represents an essential determinant of quality of life. Since significant advances in neuro-oncological treatment have led to prolonged survival it is important to reliably identify possible treatment-related neurocognitive dysfunction in brain tumor patients. Therefor...
Autores principales: | Schlömer, Sabine, Felsberg, Jörg, Pertz, Milena, Hentschel, Bettina, Löffler, Markus, Schackert, Gabriele, Krex, Dietmar, Juratli, Tareq, Tonn, Joerg Christian, Schnell, Oliver, Vatter, Hartmut, Simon, Matthias, Westphal, Manfred, Martens, Tobias, Sabel, Michael, Bendszus, Martin, Dörner, Nils, Fliessbach, Klaus, Hoppe, Christian, Reifenberger, Guido, Weller, Michael, Schlegel, Uwe, Network, for the German Glioma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325813/ https://www.ncbi.nlm.nih.gov/pubmed/35796933 http://dx.doi.org/10.1007/s11060-022-04044-1 |
Ejemplares similares
-
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up
por: Pertz, Milena, et al.
Publicado: (2023) -
Chemotherapy for intracranial ependymoma in adults
por: Gramatzki, Dorothee, et al.
Publicado: (2016) -
Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma()()
por: Stasik, Sebastian, et al.
Publicado: (2020) -
Clinical and scientific advances in neurosurgery
por: Schackert, Gabriele, et al.
Publicado: (2021) -
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development
por: Binder, H., et al.
Publicado: (2019)